Our perspectives
in one place
Topic
Selected filters
ClearNews
See allG20 3rd Health Working Group Meeting: Health Emergencies Prevention, Preparedness, and Response (HEPPR)
On 4 June, IFPMA delivered a statement on Priority I “Health Emergencies Prevention, Preparedness, and Response” at the G20 3rd Health Working Group Meeting in Hyderabad.
Read moreG20 3rd Health Working Group Meeting: Strengthening cooperation in pharmaceutical sector with focus on availability and access to safe, effective, quality, and affordable medical countermeasures (MCM) – VTDs (vaccines, therapeutics, and diagnostics)
On 4 June, IFPMA delivered a statement on Priority II “Strengthening cooperation in pharmaceutical sector with focus on availability and access to safe, effective, quality, and affordable medical countermeasures (MCM) – VTDs (vaccines, therapeutics, and diagnostics)” at the G20 3rd Health Working Group Meeting in Hyderabad.
Read moreG20 side event on Global Vaccine Research Collaborative
On 3 June, IFPMA delivered a statement at the PATH and CEPI side event on the “Global Vaccine Research Collaborative” at the G20 3rd Health Working Group Meeting in Hyderabad.
Read moreG20 3rd Health Working Group Meeting: Digital health innovations and solutions to aid Universal Health Coverage (UHC) and improve Healthcare Service Delivery
On 5 June, IFPMA delivered a statement on Priority III “Digital health innovations and solutions to aid Universal Health Coverage (UHC) and improve Healthcare Service Delivery” at the G20 3rd Health Working Group Meeting in Hyderabad.
Read moreInnovative pharmaceutical industry contributes to discussions on universal health coverage and health security during 76th World Health Assembly
On 30 May, IFPMA issued a statement summarizing their contributions to universal health coverage and health security at the 76th World Health Assembly.
Read moreIndividual statement at WHA76 on agenda items 13.1 and 13.2
On 26 May, IFPMA provided a WHA76 statement on agenda items 13.1: Reorienting health systems to primary health care as a resilient foundation for universal health coverage and preparations for a high-level meeting of the United Nations General Assembly on universal health coverage and 13.2: Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases, and mental health.
Read morePublications
See allIFPMA Note for Guidance on sponsorship of events and meetings (2023 update)
Collaborations between healthcare professionals (HCPs) and the pharmaceutical industry are essential and ensure that patients have access to the medicines they need and that healthcare professionals have up-to-date comprehensive information about the diseases they treat and the medicines they prescribe.
Read moreReinforcing collaboration on Universal Health Coverage to deliver greater global health equity and health security
The innovative pharmaceutical industry stands together with other members of the global health community to support countries in accelerating their efforts to achieve UHC. Read our position paper.
Read more
Key considerations on the scope, utility and processes around updating the WHO Essential Medicines List
The WHO Essential Medicines List (EML) is an important tool in global health and supports the achievement of the UN Sustainable Development Goals. IFPMA has published perspectives from the R&D-based industry on the utility and scope of the EML. This position paper represents IFPMA's perspective as of April 2023, ahead of the publication of the revised version of the EML.
Read moreExpert insights
See all
An ambitious World Health Assembly aims to get global health back on track
Read more
#AlwaysInnovating: The importance of pharmaceutical innovation
Read more
Clinical trials: Ethics, innovation, and how to achieve greater equity and equality
Read moreResources
See allNavigating the ECOWAS Joint Assessment Procedure
The ECOWAS Joint Assessment Procedure is a collaborative initiative among 15 National Regulatory Agencies in West Africa that ensures harmonized and streamlined market authorization of medical products across the region. This infographic provides an overview of key steps and timelines applicants need to bear in mind during the Joint Assessment Procedure.
Read more
Advancing universal health coverage in Africa
Universal Health Coverage (UHC) is at the heart of the health-related Sustainable Development Goals (SDGs). It is the foundation for both global health security and the health and well-being of all people throughout their lifetimes. Africa’s health systems are essential in delivering the UHC2030 action agenda. Given Africa’s population is expected to double by 2050,...
Read more
Collaborating to achieve universal health coverage
Discover how the innovative pharmaceutical industry is embracing partnerships to accelerate action on SDG 3 and other global goals in this infographic.
Read more